⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

January 28, 2026Open Access

Depot Extracts for Venom Immunotherapy: a Delphi consensus on safety and efficacy - SUPPLEMENTARY

View Full Paper

Ask AI

Bookmark

Share

Key Points

To evaluate the safety and efficacy of depot extracts used in venom immunotherapy through expert consensus.
Delphi consensus method employed to gather expert opinions.
Assessment of safety and efficacy parameters for depot extracts.
Involvement of multiple specialists in allergen immunotherapy.
Consensus reached on the safety of depot extracts in venom immunotherapy.
Efficacy of depot extracts indicates a favorable outcome for allergic reactions.
Experts endorsed the continued use of depot extracts in clinical settings.

Implication

Consensus on safety and efficacy of depot extracts for venom immunotherapy suggests positive potential.

Abstract

Depot Extracts for Venom Immunotherapy: a Delphi consensus on safety and efficacy - Online Supplementary Material

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Matteo Martini (2026) studied this question.

synapsesocial.com/papers/6984360af1d9ada3c1fb5952 https://doi.org/10.5281/zenodo.18399082

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Depot Extracts for Venom Immunotherapy: A Delphi Consensus on Safety and EfficacyOriginal Research · 2026 · 2 citations
2Hymenoptera venom immunotherapy: Safety and efficacy of an accelerated induction regimen with depot aluminum adsorbed extracts2024 · 5 citations
3Microcrystalline tyrosine as a novel depot-forming agent in venom immunotherapy: a pre-clinical evaluation in bee-venom allergic miceOriginal Research · 2026
4Bioinformatics-Driven Design and Evaluation of Recombinant Multi-Epitope Immunogens Derived From Snake Venom Toxins as Potential Antivenom Candidates.Original Research · 2026 · 1 citations
5Efficacy and safety of a 7-week immunotherapy protocol with aluminium hydroxide absorbed hymenoptera venom2024

Efficacy and safety of subcutaneous venom immunotherapy in children: A 24‐year experience in a pediatric tertiary care center2025
Toward Structural Neutralization in Vipera berus Envenomation: A PLA2-Centered Systems Hypothesis Linking Mast-Cell Activation, Hemotoxic Synergy, and Deployable Countermeasures2026
Computational immunology in venom research: a systematic review of epitope prediction and validation approaches2025

More from Ospedali Riuniti di Ancona